Angi (ANGI) COO: 10,000 RSUs vested; 3,010 shares disposed

Angi (ANGI) reported insider activity by its Chief Operating Officer on 10/15/2025.

Rhea-AI Filing Summary

Angi (ANGI) reported insider activity by its Chief Operating Officer on 10/15/2025. The officer acquired 10,000 shares of Class A Common Stock upon RSU conversion and disposed of 3,010 shares at $14.08. Following these transactions, directly held common shares were 20,156. Derivative holdings included 30,000 restricted stock units.

The figures reflect a 1-for-10 reverse stock split effective March 24, 2025. The filing also corrects prior administrative errors regarding vesting and date entries tied to RSUs granted on October 15, 2024, which vest in four equal annual installments beginning on the first anniversary of the grant date.

Insider Trade Summary

10,000 shares exercised/converted

Exercise 3 txns

Insider Carson Bailey

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	10,000	$0.00	$0.00
Exercise	Class A Common Stock, par value $0.001	10,000	$0.00	$0.00
Exercise Price or Tax Liability	Class A Common Stock, par value $0.001	3,010	$14.08	$42K

Holdings After Transaction: Restricted Stock Units — 30,000 contracts (Direct); Class A Common Stock, par value $0.001 — 20,156 shares (Direct)

Footnotes (4)

1. F1. Restricted stock units convert into Class A Common Stock on a one-for-one basis.
2. F2. Effective on March 24, 2025, the Issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
3. F3. Due to an administrative error, the Form 4 previously filed with the Securities and Exchange Commission on October 17, 2024 (the "Previous Form 4") misreported the date exercisable and expiration date as 11/1/2025 and 11/1/2028, respectively.
4. F4. On October 15, 2024, the reporting person was granted 400,000 restricted stock units (on a pre-Reverse Stock Split basis), vesting in four equal annual installments beginning on the first anniversary of the grant date, subject to continued service. Due to an administrative error, the Previous Form 4 misreported the subsequent vesting dates as November 1, 2025, 2026, 2027 and 2028.

FAQ

What insider transaction did ANGI’s COO report?

On 10/15/2025, the COO acquired 10,000 shares via RSU conversion and disposed of 3,010 shares at $14.08.

How many ANGI shares does the COO hold after the transaction?

Directly held Class A Common Stock totaled 20,156 shares after the reported transactions.

How many RSUs does the ANGI COO still hold?

The filing shows 30,000 restricted stock units beneficially owned following the transaction.

Were the reported numbers adjusted for any corporate action at ANGI?

Yes. Amounts were adjusted for a 1-for-10 reverse stock split effective March 24, 2025.

Did the filing correct any prior errors related to ANGI equity awards?

Yes. It corrects previously misreported exercisable/expiration dates and vesting dates tied to RSUs granted on October 15, 2024.

What price is shown for the disposed ANGI shares?

The disposed shares are listed at $14.08.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/17/2025 - 05:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carson Bailey

(Last) (First) (Middle)

C/O ANGI INC.

3601 WALNUT STREET, SUITE 700

(Street)

DENVER CO 80205

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Angi Inc. [ ANGI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock, par value $0.001	10/15/2025		M		10,000	A	(1)	23,166(2)	D
Class A Common Stock, par value $0.001	10/15/2025		F		3,010	D	$14.08	20,156	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	10/15/2025		M			10,000	(3)(4)	(3)(4)	Class A Common Stock, par value $0.001	10,000	$0	30,000	D

Explanation of Responses:

1. Restricted stock units convert into Class A Common Stock on a one-for-one basis.

2. Effective on March 24, 2025, the Issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

3. Due to an administrative error, the Form 4 previously filed with the Securities and Exchange Commission on October 17, 2024 (the "Previous Form 4") misreported the date exercisable and expiration date as 11/1/2025 and 11/1/2028, respectively.

4. On October 15, 2024, the reporting person was granted 400,000 restricted stock units (on a pre-Reverse Stock Split basis), vesting in four equal annual installments beginning on the first anniversary of the grant date, subject to continued service. Due to an administrative error, the Previous Form 4 misreported the subsequent vesting dates as November 1, 2025, 2026, 2027 and 2028.

Remarks:

	/s/ Shannon M. Shaw as Attorney-in-Fact for Bailey Carson	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.